Biblio Discovery — Demo Discovery Service

10 results for "Fengling Feng"

Showing 1–10 · 0.41 seconds · RSS

  1. Journal Article Full text

    Preexisting Virus-Specific T Lymphocytes-Mediated Enhancement of Adenovirus Infections to Human Blood CD14+ Cells

    Fengling Feng; Jin Zhao; Pingchao Li et al.

    Viruses, Vol. 11 No. 2 · 2019 · English · DOAJ Scopus

    Antigen-specific T lymphocytes play a critical role in controlling viral infections. However, we report here that preexisting virus-specific T cell responses also contribute to promoting adenovirus (Ad) infection. Previously, we found that CD14+ monocytes from Ad-seropositive individuals exhibited…

  2. Journal Article Full text

    Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection

    Fengling Feng; Jiaoshan Chen; Jin Zhao et al.

    Viruses, Vol. 13 No. 11 · 2021 · English · DOAJ Scopus

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters host cells mainly by the angiotensin converting enzyme 2 (ACE2) receptor, which can recognize the spike (S) protein by its extracellular domain. Previously, recombinant soluble ACE2 (sACE2) has been clinically used as a…

  3. Journal Article Full text

    Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases

    Fengling Feng; Ziyu Wen; Jiaoshan Chen et al.

    Viruses, Vol. 14 No. 3 · 2022 · English · DOAJ Scopus

    Numerous pathogenic microbes, including viruses, bacteria, and fungi, usually infect the host through the mucosal surfaces of the respiratory tract, gastrointestinal tract, and reproductive tract. The mucosa is well known to provide the first line of host defense against pathogen entry by physical…

  4. Journal Article

    Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys

    Enxiang Pan; Fengling Feng; Pingchao Li et al.

    Frontiers in Immunology, Vol. 9 · 2018 · English · DOAJ Scopus

    Though immune correlates for protection are still under investigation, potent cytotoxic T lymphocyte responses are desirable for an ideal HIV-1 vaccine. PD-1 blockade enhances SIV-specific CD8+ T cells. However, little information has been reported about how it affects the immunogenicity and…

  5. Journal Article

    Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

    Musha Chen; Yue Yuan; Yiguo Zhou et al.

    Infectious Diseases of Poverty, Vol. 10 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively approved for marketing worldwide. A comprehensive review for clinical trials assessing the safety of COVID-19 vaccines is…

  6. Journal Article

    An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination

    Musha Chen; Yanjun Li; Jiaoshan Chen et al.

    Human Vaccines & Immunotherapeutics, Vol. 17 No. 7 · 2021 · English · DOAJ Scopus

    Background: A safe and effective vaccine against COVID-19 has become a public health priority. However, little is known about the public willingness to accept a future COVID-19 vaccine in China. This study aimed to understand the willingness and determinants for the acceptance of a COVID-19 vaccine…

  7. Journal Article

    Comparison of the Immunogenicity of HIV-1 CRF07_BC Gag Antigen With or Without a Seven Amino Acid Deletion in p6 Region

    Minchao Li; Yue Yuan; Pingchao Li et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    HIV-1 CRF07_BC-p6Δ7, a strain with a seven amino acid deletion in the p6 region of the Gag protein, is becoming the dominant strain of HIV transmission among men who have sex with men (MSM) in China. Previous studies demonstrated that HIV-1 patients infected by CRF07_BC-p6Δ7 strain had lower viral…

  8. Journal Article

    Immune Control of AIDS Progression by an Adenovirus‐Based Therapeutic Vaccination in Acute Simian Immunodeficiency Virus‐Infected Macaques

    Yizi He; Chunxiu Wu; Fengling Feng et al.

    MedComm, Vol. 6 No. 8 · 2025 · English · DOAJ Scopus

    ABSTRACT Therapeutic vaccinations that enhance human immunodeficiency virus (HIV)‐specific immunity hold promise for reducing reliance on antiretroviral therapy (ART). We previously developed an adenovirus vector‐infected peripheral blood mononuclear cell (AVIP) as a prophylactic strategy that…

  9. Journal Article

    Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV‐Infected Macaques

    Qing Yang; Fengling Feng; Pingchao Li et al.

    Advanced Science, Vol. 6 No. 13 · 2019 · English · DOAJ Scopus

    Abstract The latent viral reservoir is the source of viral rebound after interruption of antiretroviral therapy (ART) and is the major obstacle in eradicating the latent human immunodeficiency virus‐1 (HIV‐1). In this study, arsenic class of mineral, arsenic trioxide, clinically approved for…

  10. Journal Article

    Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques

    Yizi He; Chunxiu Wu; Zijian Liu et al.

    Microbiology Spectrum, Vol. 11 No. 5 · 2023 · English · DOAJ Scopus

    ABSTRACT Latent viral reservoir is recognized as the major obstacle to achieving a functional cure for HIV infection. We previously reported that arsenic trioxide (As2O3) combined with antiretroviral therapy (ART) can reactivate the viral reservoir and delay viral rebound after ART interruption in…